Skip to main content
main-content
Erschienen in: Current Treatment Options in Oncology 12/2021

24.11.2021 | COVID-19 | Gynecologic Cancers (LA Cantrell, Section Editor) Zur Zeit gratis

COVID-19 and Gynecologic Oncology: What Have We Learned?

verfasst von: MD Aurora Leibold, MD Katyayani Papatla, MD Kristen P. Zeligs, MD Stephanie V. Blank

Erschienen in: Current Treatment Options in Oncology | Ausgabe 12/2021

Einloggen, um Zugang zu erhalten

Opinion statement

COVID-19 has transformed the care we provide to gynecologic oncology patients. In addition to directly impacting the diagnosis and treatment of women with gynecologic cancer, it has affected our patient’s ability to undergo recommended surveillance and has made an impact on every caregiver providing care during this time. Herein we review the current literature on the impact of COVID-19 on gynecologic oncology and highlight new approaches and innovations that have resulted in gynecologic cancer care as a result of the pandemic. The impact of COVID-19 on the field of gynecologic oncology has been profound. In addition to directly impacting the diagnosis and treatment of women with cancer, it has also challenged the very ethics with which we practice medicine. The equitable distribution of resources is paramount to upholding the Hippocratic Oath which we all invoke. The COVID-19 pandemic has stripped this oath down to its very core, forcing all medical practitioners to scrutinize who gets what resources and when. As the pandemic continues to unfold, the question remains — in the setting of a strained and overburdened healthcare system, how do we maximize beneficence to one group of patients, while maintaining non-maleficence to others? As gynecologic oncologists, we are responsible for advocating for our patients to ensure that the quality of their cancer care is not compromised, while also not overutilizing resources that are sorely needed for the care of COVID-19 victims, and not making them more likely to succumb to COVID-19 by the very nature of the treatment we provide. The effects of the pandemic are far-reaching and broad, and many of these are yet to be determined. Future studies are needed to analyze how the above-utilized strategies in GYN cancer care during the pandemic will impact the long-term outcomes of our patients.
Literatur
2.
Zurück zum Zitat Frey MK, Fowlkes RK, Badiner NM, Fishman D, Kanis M, Thomas C, Christos PJ, Martin P, Gamble C, Balogun OD, Cardenes H, Gorelick C, Pua T, Nguyen L, Holcomb K, Chapman-Davis E. Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitals. Gynecol Oncol. 2020;159(2):470–5. CrossRef Frey MK, Fowlkes RK, Badiner NM, Fishman D, Kanis M, Thomas C, Christos PJ, Martin P, Gamble C, Balogun OD, Cardenes H, Gorelick C, Pua T, Nguyen L, Holcomb K, Chapman-Davis E. Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitals. Gynecol Oncol. 2020;159(2):470–5. CrossRef
4.
Zurück zum Zitat •• Lara OD, O’Cearbhaill RE, Smith MJ, Sutter ME, Knisely A, McEachron J, Gabor LR, Jee J, Fehniger JE, Lee YC, Isani SS, Wright JD, Pothuri B. COVID-19 outcomes of patients with gynecologic cancer in New York City. Cancer. 2020;126(19):4294–303. This study was the first large series examining COVID-19 infections in a single sex with a specific cancer type. It provided early insight into the risk factors associated with increased morbidity and mortality among gynecologic oncology patients with COVID-19 infections. CrossRef •• Lara OD, O’Cearbhaill RE, Smith MJ, Sutter ME, Knisely A, McEachron J, Gabor LR, Jee J, Fehniger JE, Lee YC, Isani SS, Wright JD, Pothuri B. COVID-19 outcomes of patients with gynecologic cancer in New York City. Cancer. 2020;126(19):4294–303. This study was the first large series examining COVID-19 infections in a single sex with a specific cancer type. It provided early insight into the risk factors associated with increased morbidity and mortality among gynecologic oncology patients with COVID-19 infections. CrossRef
5.
Zurück zum Zitat Ciavattini A, Delli Carpini G, Giannella L, Arbyn M, Kyrgiou M, Joura EA, Sehouli J, Carcopino X, Redman CW, Nieminen P, Cruickshank M, Gultekin M. European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic. Int J Gynecol Cancer. 2020;30(8):1097–100. CrossRef Ciavattini A, Delli Carpini G, Giannella L, Arbyn M, Kyrgiou M, Joura EA, Sehouli J, Carcopino X, Redman CW, Nieminen P, Cruickshank M, Gultekin M. European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic. Int J Gynecol Cancer. 2020;30(8):1097–100. CrossRef
7.
Zurück zum Zitat Gorin SNS, Jimbo M, Heizelman R, Harmes KM, Harper DM. The future of cancer screening after COVID-19 may be at home. Cancer. 2021;127(4):498–503. CrossRef Gorin SNS, Jimbo M, Heizelman R, Harmes KM, Harper DM. The future of cancer screening after COVID-19 may be at home. Cancer. 2021;127(4):498–503. CrossRef
8.
Zurück zum Zitat Polman NJ, de Haan Y, Veldhuijzen NJ, et al. Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands. Prev Med. 2019;125:5–11. CrossRef Polman NJ, de Haan Y, Veldhuijzen NJ, et al. Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands. Prev Med. 2019;125:5–11. CrossRef
9.
Zurück zum Zitat Suh-Burgmann EJ, Alavi M, Schmittdiel J. Endometrial cancer detection during the coronavirus disease 2019 (COVID-19) pandemic. Obstet Gynecol. 2020;136(4):842–3. CrossRef Suh-Burgmann EJ, Alavi M, Schmittdiel J. Endometrial cancer detection during the coronavirus disease 2019 (COVID-19) pandemic. Obstet Gynecol. 2020;136(4):842–3. CrossRef
10.
Zurück zum Zitat Akladios C, Azais H, Ballester M, et al. Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF. J Gynecol Obstet Hum Reprod 2020;49. Akladios C, Azais H, Ballester M, et al. Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF. J Gynecol Obstet Hum Reprod 2020;49.
11.
Zurück zum Zitat •• Fader AN, Huh WK, Kesterson J, et al. When to operate, hesitate, and reintegrate: society of gynecologic oncology surgical considerations during the COVID-19 pandemic. Gynecol Oncol. 2020;158(2):236–43. Key SGO guidelines for surgical management of gynecologic oncology patients during the pandemic. CrossRef •• Fader AN, Huh WK, Kesterson J, et al. When to operate, hesitate, and reintegrate: society of gynecologic oncology surgical considerations during the COVID-19 pandemic. Gynecol Oncol. 2020;158(2):236–43. Key SGO guidelines for surgical management of gynecologic oncology patients during the pandemic. CrossRef
12.
Zurück zum Zitat Matsuo K, Novatt H, Matsuzaki S, Hom MS, Castaneda AV, Licon E, Nusbaum DJ, Roman LD. Wait-time for hysterectomy and survival of women with early-stage cervical cancer: a clinical implication during the coronavirus pandemic. Gynecol Oncol. 2020;158(1):37–43. CrossRef Matsuo K, Novatt H, Matsuzaki S, Hom MS, Castaneda AV, Licon E, Nusbaum DJ, Roman LD. Wait-time for hysterectomy and survival of women with early-stage cervical cancer: a clinical implication during the coronavirus pandemic. Gynecol Oncol. 2020;158(1):37–43. CrossRef
13.
Zurück zum Zitat Matsuo K, Huang Y, Matsuzaki S, Klar M, Wright JD. Effect of delay in surgical therapy for early-stage cervical cancer: an implication in the coronavirus pandemic. Eur J Cancer. 2020;139:173–6. CrossRef Matsuo K, Huang Y, Matsuzaki S, Klar M, Wright JD. Effect of delay in surgical therapy for early-stage cervical cancer: an implication in the coronavirus pandemic. Eur J Cancer. 2020;139:173–6. CrossRef
14.
Zurück zum Zitat Bogani G, Ditto A, De Cecco L, Lopez S, Guerrisi R, Piccioni F, Micali A, Daidone MG, Raspagliesi F. Transmission of SARS-CoV-2 in surgical smoke during laparoscopy: a prospective, proof-of-concept study. J Minim Invasive Gynecol. 2020;S1553–4650(20):31200. Bogani G, Ditto A, De Cecco L, Lopez S, Guerrisi R, Piccioni F, Micali A, Daidone MG, Raspagliesi F. Transmission of SARS-CoV-2 in surgical smoke during laparoscopy: a prospective, proof-of-concept study. J Minim Invasive Gynecol. 2020;S1553–4650(20):31200.
15.
Zurück zum Zitat de Leeuw RA, Burger NB, Ceccaroni M, Zhang J, Tuynman J, Mabrouk M, BarriSoldevila P, Bonjer HJ, Ankum P, Huirne J. COVID-19 and laparoscopic surgery: scoping review of current literature and local expertise. JMIR Public Health Surveill. 2020;6(2):e18928. CrossRef de Leeuw RA, Burger NB, Ceccaroni M, Zhang J, Tuynman J, Mabrouk M, BarriSoldevila P, Bonjer HJ, Ankum P, Huirne J. COVID-19 and laparoscopic surgery: scoping review of current literature and local expertise. JMIR Public Health Surveill. 2020;6(2):e18928. CrossRef
16.
Zurück zum Zitat Kimmig R, Verheijen RHM, Rudnicki M, for SERGS Council. Robot assisted surgery during the COVID-19 pandemic, especially for gynecological cancer: a statement of the Society of European Robotic Gynaecological Surgery (SERGS). J Gynecol Oncol. 2020;31(3):e59. CrossRef Kimmig R, Verheijen RHM, Rudnicki M, for SERGS Council. Robot assisted surgery during the COVID-19 pandemic, especially for gynecological cancer: a statement of the Society of European Robotic Gynaecological Surgery (SERGS). J Gynecol Oncol. 2020;31(3):e59. CrossRef
17.
Zurück zum Zitat • Glasbey JC, Nepogodiev D, Simoes JFF, et al. Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study. J Clin Oncol. 2021;39(1):66–78. This paper demonstrates a critical component of the safe resumption of elective surgery during a pandemic. The methods described by the authors demonstrate that when able, complete segregation of operative pathways can allow for the resumption of elective surgery while still protecting patients from COVID-19 complications. CrossRef • Glasbey JC, Nepogodiev D, Simoes JFF, et al. Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study. J Clin Oncol. 2021;39(1):66–78. This paper demonstrates a critical component of the safe resumption of elective surgery during a pandemic. The methods described by the authors demonstrate that when able, complete segregation of operative pathways can allow for the resumption of elective surgery while still protecting patients from COVID-19 complications. CrossRef
18.
Zurück zum Zitat • Elledge CR, Beriwal S, Chargari C, et al. Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: international expert consensus recommendations. Gynecol Oncol. 2020;158(2):244–53. Expert international consensus from radiation oncology specialists regarding the prioritization of radiation therapy in gynecologic oncology patients. CrossRef • Elledge CR, Beriwal S, Chargari C, et al. Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: international expert consensus recommendations. Gynecol Oncol. 2020;158(2):244–53. Expert international consensus from radiation oncology specialists regarding the prioritization of radiation therapy in gynecologic oncology patients. CrossRef
19.
Zurück zum Zitat Williams VM, Kahn JM, Harkenrider MM, et al. COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation. Brachytherapy. 2020;19(4):401–11. CrossRef Williams VM, Kahn JM, Harkenrider MM, et al. COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation. Brachytherapy. 2020;19(4):401–11. CrossRef
20.
Zurück zum Zitat Han K, Mendez L, D’Souza D, et al. Management of gynecologic cancer: choosing radiotherapy wisely by 3 Southern Ontario academic centers during the COVID-19 pandemic. Radiother Oncol. 2020;151:15–6. CrossRef Han K, Mendez L, D’Souza D, et al. Management of gynecologic cancer: choosing radiotherapy wisely by 3 Southern Ontario academic centers during the COVID-19 pandemic. Radiother Oncol. 2020;151:15–6. CrossRef
21.
Zurück zum Zitat Yeramilli D, Xu A, Gillespie E, et al. Palliative radiation therapy for oncologic emergencies in the setting of COVID-19: approaches to balancing risks and benefits. Adv Radiat Oncol. 2020;5(4):589–94. CrossRef Yeramilli D, Xu A, Gillespie E, et al. Palliative radiation therapy for oncologic emergencies in the setting of COVID-19: approaches to balancing risks and benefits. Adv Radiat Oncol. 2020;5(4):589–94. CrossRef
22.
Zurück zum Zitat •• Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan. China JAMA Oncol. 2020;6(7):1108–10. This is an early landmark study demonstrating the higher incidence of COVID-19 infections among patients with solid cancers out of a large cohort of COVID-19 patients in Wuhan, China. CrossRef •• Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan. China JAMA Oncol. 2020;6(7):1108–10. This is an early landmark study demonstrating the higher incidence of COVID-19 infections among patients with solid cancers out of a large cohort of COVID-19 patients in Wuhan, China. CrossRef
23.
Zurück zum Zitat •• Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–7. Another landmark study from China demonstrating the increased risks of COVID-19 infection in cancer patients. This paper demonstrates the vulnerability of this population, including increased rates of ICU admission, mechanical ventilation, and death. CrossRef •• Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–7. Another landmark study from China demonstrating the increased risks of COVID-19 infection in cancer patients. This paper demonstrates the vulnerability of this population, including increased rates of ICU admission, mechanical ventilation, and death. CrossRef
24.
Zurück zum Zitat • Pothuri B, Alvarez Secord A, Armstrong DK, Chan J, Fader AN, Huh W, Kesterson J, Liu JF, Moore K, Westin SN, Naumann RW. Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis. Gynecol Oncol. 2020;158(1):16–24. Excellent recommendations for the approach to systemic therapy and considerations for clinical trial enrollment for gynecologic oncology patients during the pandemic. CrossRef • Pothuri B, Alvarez Secord A, Armstrong DK, Chan J, Fader AN, Huh W, Kesterson J, Liu JF, Moore K, Westin SN, Naumann RW. Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis. Gynecol Oncol. 2020;158(1):16–24. Excellent recommendations for the approach to systemic therapy and considerations for clinical trial enrollment for gynecologic oncology patients during the pandemic. CrossRef
25.
Zurück zum Zitat Monk BJ, Coleman RL, Moore KN, Herzog TJ, Secord AA, Matulonis UA, Slomovitz BM, Guntupalli SR, O’Malley DM. COVID-19 and ovarian cancer: exploring alternatives to intravenous (IV) therapies. Gynecol Oncol. 2020;158(1):34–6. CrossRef Monk BJ, Coleman RL, Moore KN, Herzog TJ, Secord AA, Matulonis UA, Slomovitz BM, Guntupalli SR, O’Malley DM. COVID-19 and ovarian cancer: exploring alternatives to intravenous (IV) therapies. Gynecol Oncol. 2020;158(1):34–6. CrossRef
26.
Zurück zum Zitat Vetter MH, Smrz SA, Copeland LJ, Cohn DE. Chemotherapy directly followed by poly(ADP-ribose) polymerase inhibition as an alternative to surgery in patients with BRCA-mutated ovarian cancer: a potential management strategy in the era of coronavirus disease 2019. Am J Obstet Gynecol. 2020;223(3):469–70. CrossRef Vetter MH, Smrz SA, Copeland LJ, Cohn DE. Chemotherapy directly followed by poly(ADP-ribose) polymerase inhibition as an alternative to surgery in patients with BRCA-mutated ovarian cancer: a potential management strategy in the era of coronavirus disease 2019. Am J Obstet Gynecol. 2020;223(3):469–70. CrossRef
28.
Zurück zum Zitat Xia Y, Jin R, Zhao J, et al. Risk of COVID-19 for cancer patients. Lancet Oncol. 2020;21(4):e180. CrossRef Xia Y, Jin R, Zhao J, et al. Risk of COVID-19 for cancer patients. Lancet Oncol. 2020;21(4):e180. CrossRef
29.
Zurück zum Zitat Mancebo G, Solé-Sedeño J-M, Membrive I, Taus A, Castells M, Serrano L, Carreras R, Miralpei E. Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19). Int J Gynecol Cancer. 2020;0:1–6. Mancebo G, Solé-Sedeño J-M, Membrive I, Taus A, Castells M, Serrano L, Carreras R, Miralpei E. Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19). Int J Gynecol Cancer. 2020;0:1–6.
30.
Zurück zum Zitat Lai J, Ma S, Wang Y, et al. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open. 2020;3(3):e203976. CrossRef Lai J, Ma S, Wang Y, et al. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open. 2020;3(3):e203976. CrossRef
31.
Zurück zum Zitat Thomaier L, Teoh D, Jewett P, Beckwith H, Parsons H, Yuan J, Blaes AH, Lou E, Hui JYC, Vogel RI. Emotional health concerns of oncology physicians in the United States: fallout during the COVID-19 pandemic. PLoS ONE. 2020;15(11):e0242767. CrossRef Thomaier L, Teoh D, Jewett P, Beckwith H, Parsons H, Yuan J, Blaes AH, Lou E, Hui JYC, Vogel RI. Emotional health concerns of oncology physicians in the United States: fallout during the COVID-19 pandemic. PLoS ONE. 2020;15(11):e0242767. CrossRef
32.
Zurück zum Zitat Wu Y, Wang J, Luo C, et al. A comparison of burnout frequency among oncology physicians and nurses working on the front lines and usual wards during the COVID-19 epidemic in Wuhan, China. J Pain Symptom Manage. 2020;60(1):e60–5. CrossRef Wu Y, Wang J, Luo C, et al. A comparison of burnout frequency among oncology physicians and nurses working on the front lines and usual wards during the COVID-19 epidemic in Wuhan, China. J Pain Symptom Manage. 2020;60(1):e60–5. CrossRef
33.
Zurück zum Zitat Shanafelt T, Ripp J, Trockel M. Understanding and addressing sources of anxiety among health care professionals during the COVID-19 pandemic. JAMA. 2020;323(21):2133–4. CrossRef Shanafelt T, Ripp J, Trockel M. Understanding and addressing sources of anxiety among health care professionals during the COVID-19 pandemic. JAMA. 2020;323(21):2133–4. CrossRef
34.
Zurück zum Zitat Zimmerman BS, Seidman D, Berger N, Cascetta KP, Nezolosky M, Trlica K, Ryncarz A, Keeton C, Moshier E, Tiersten A. Patient perception of telehealth services for breast and gynecologic oncology care during the COVID-19 pandemic: a single center survey-based study. J Breast Cancer. 2020;23(5):542–52. CrossRef Zimmerman BS, Seidman D, Berger N, Cascetta KP, Nezolosky M, Trlica K, Ryncarz A, Keeton C, Moshier E, Tiersten A. Patient perception of telehealth services for breast and gynecologic oncology care during the COVID-19 pandemic: a single center survey-based study. J Breast Cancer. 2020;23(5):542–52. CrossRef
35.
Zurück zum Zitat Mojdehbakhsh RP, Rose S, Peterson M, Rice L, Spencer R. A quality improvement pathway to rapidly increase telemedicine services in a gynecologic oncology clinic during the COVID-19 pandemic with patient satisfaction scores and environmental impact. Gynecol Oncol Rep. 2021;22:100708. CrossRef Mojdehbakhsh RP, Rose S, Peterson M, Rice L, Spencer R. A quality improvement pathway to rapidly increase telemedicine services in a gynecologic oncology clinic during the COVID-19 pandemic with patient satisfaction scores and environmental impact. Gynecol Oncol Rep. 2021;22:100708. CrossRef
36.
Zurück zum Zitat Ramirez PT, Chiva L, Eriksson AGZ, Frumovitz M, Fagotti A, Gonzalez Martin A, Jhingran A, Pareja R. COVID-19 global pandemic: options for management of gynecologic cancers. Int J Gynecol Cancer. 2020;30(5):561–3. CrossRef Ramirez PT, Chiva L, Eriksson AGZ, Frumovitz M, Fagotti A, Gonzalez Martin A, Jhingran A, Pareja R. COVID-19 global pandemic: options for management of gynecologic cancers. Int J Gynecol Cancer. 2020;30(5):561–3. CrossRef
37.
Zurück zum Zitat Uwins C, Bhandoria GP, Shylasree T, et al. COVID-19 and gynecological cancer: a review of the published guidelines. Int J Gynecol Cancer. 2020;30:1424–33. CrossRef Uwins C, Bhandoria GP, Shylasree T, et al. COVID-19 and gynecological cancer: a review of the published guidelines. Int J Gynecol Cancer. 2020;30:1424–33. CrossRef
38.
Zurück zum Zitat Moran HK, Brooks JV, Spoozak L. Undergoing active treatment for gynecologic cancer during COVID-19: a qualitative study of the impact on healthcare and social support. Gynecol Oncol Rep. 2020;34:100659. CrossRef Moran HK, Brooks JV, Spoozak L. Undergoing active treatment for gynecologic cancer during COVID-19: a qualitative study of the impact on healthcare and social support. Gynecol Oncol Rep. 2020;34:100659. CrossRef
Metadaten
Titel
COVID-19 and Gynecologic Oncology: What Have We Learned?
verfasst von
MD Aurora Leibold
MD Katyayani Papatla
MD Kristen P. Zeligs
MD Stephanie V. Blank
Publikationsdatum
24.11.2021
Verlag
Springer US
Schlagwort
COVID-19
Erschienen in
Current Treatment Options in Oncology / Ausgabe 12/2021
Print ISSN: 1527-2729
Elektronische ISSN: 1534-6277
DOI
https://doi.org/10.1007/s11864-021-00905-5

Weitere Artikel der Ausgabe 12/2021

Current Treatment Options in Oncology 12/2021 Zur Ausgabe

Cardio-oncology (MG Fradley, Section Editor)

The Importance of Primary Care in Cardio-Oncology

Neuro-oncology (GJ Lesser, Section Editor)

Systemic Therapy for Lung Cancer Brain Metastases

Gynecologic Cancers (LA Cantrell, Section Editor)

Options for the Treatment of Mucinous Ovarian Carcinoma

Corona-Update

Die aktuelle Entwicklung im Überblick: Nachrichten, Webinare, Übersichtsarbeiten.